Search Results for: regulator

Sputnik Light phase 3 trial denied in India; why Dr Reddy's didn't get approval for Russia's single shot vaccine

So far, the Phase 3 trials of Sputnik Light have been conducted in Russia, Ghana and UAE. The expert committee did not find any scientific basis to conduct Phase 3 trials since the immunogenicity data available from the first dose trial was not so great.

Jul 1, 2021

Dangerous Pathogenic Bacteria Rendered Almost Harmless; Crucial Mechanism Key In Virulence [Details]

According to a new study by scientists from the University of Geneva (UNIGE), a newly identified regulator of gene expression of Pseudomonas aeruginosa bacteria is responsible for its pathogenicity.

Jun 23, 2021

SEBI halts PNB Housing's preferential share offering of Rs 4,000 crore; Here's why

The Securities and Exchange Board of India (SEBI) has ordered PNB Housing Finance to postpone a proposed preferential offer of up to Rs 4,000 crore in shares to Carlyle Group Inc.-controlled companies.

Jun 21, 2021

Scientists identify Covid's link to life threatening blood clots in patients

A team of scientists has identified how and why some Covid-19 patients can develop life-threatening blood clots.

Jun 16, 2021

india electricity, china india relations, china electricity

Electricity bills in Karnataka get dearer; Congress protests, calls it "BJP shock"

Protesting the hike, Congress leader Siddaramaiah said the increase in power tariff would be disastrous for everyone, from common man to industries, which have been suffering due to the pandemic.

Jun 9, 2021

Franklin Templeton APAC head Vivek Kudva may appeal against SEBI ban

After the Securities and Exchange Board of India (SEBI) imposed a one-year suspension on Vivek Kudva, the Head of Asia Pacific Distribution for Franklin Templeton, he is considering appealing the ruling to the Securities Appellate Tribunal (SAT).

Jun 8, 2021

Affordable drug used for treating tapeworm infection proven effective against COVID; trials underway

Being held at different sites, phase-II clinical trial of Niclosamide beings for treating COVID will be completed within 8-12 weeks.

Jun 6, 2021

Infosys begins internal probe after SEBI order over insider trading

Software major Infosys has said that it has initiated an internal investigation in the matter of insider trading in its scrip wherein SEBI has barred two of its employees among others.

Jun 2, 2021

First evidence of COVID-19 hijacking crucial protein to invade cells found; here's how it could help

A study by researchers from Keck School of Medicine of USC is the first to experimentally demonstrate that GRP78, a molecular chaperone, plays a crucial role in the invasion of human cells by the SARS-CoV-2 coronavirus and its variants.

May 25, 2021

JD-S wants to distribute DRDO's anti-Covid drug to Karnataka's people

As Karnataka battles the second wave of Covid, Janata Dal-S leader H.D. Kumaraswamy on Tuesday said that the party was mulling buying stocks of the indigenously developed anti-Covid drug to distribute among the state's people.

May 19, 2021

Covishield side effects remain minuscule in India; watch out for these signs

In a bid to allay those fears, a panel on AEFI (adverse events following immunisation) told the Union Health Ministry on Monday that the number of bleeding and clotting events after getting a COVID jab in India remains minuscule.

May 18, 2021

DCGI allows Phase II-III clinical trial of Covaxin on children of 2 to 18 years age group

The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of Covaxin (Covid vaccine) in the age group of two to 18-years-old to its manufacturer Bharat Biotech Ltd, Union Health Ministry said on Thursday.

May 13, 2021

Prev 9 10 11 12 13 14 15 16 17 18 Next

Search Results for: regulator

Sputnik Light phase 3 trial denied in India; why Dr Reddy's didn't get approval for Russia's single shot vaccine

Dangerous Pathogenic Bacteria Rendered Almost Harmless; Crucial Mechanism Key In Virulence [Details]

SEBI halts PNB Housing's preferential share offering of Rs 4,000 crore; Here's why

Scientists identify Covid's link to life threatening blood clots in patients

Electricity bills in Karnataka get dearer; Congress protests, calls it "BJP shock"

Franklin Templeton APAC head Vivek Kudva may appeal against SEBI ban

Affordable drug used for treating tapeworm infection proven effective against COVID; trials underway

Infosys begins internal probe after SEBI order over insider trading

First evidence of COVID-19 hijacking crucial protein to invade cells found; here's how it could help

JD-S wants to distribute DRDO's anti-Covid drug to Karnataka's people

Covishield side effects remain minuscule in India; watch out for these signs

DCGI allows Phase II-III clinical trial of Covaxin on children of 2 to 18 years age group

Pfizer donating India medicines worth $70 million despite its vaccine pending for nod

Sensex down 400 points; Compliance norms eased for companies amid Covid crisis

Over 14 Cr doses of Covid vaccine administered in India in first 100 days (Details)

Time for India to follow suit? France, Germany, Netherlands, US banned use of EVMs [here's why]

Dhanush's Captain Miller has no buyers in Telugu states? Here's why

Deepika Padukone is a sight to behold in velvet gown; attends Academy Museum Gala with Selena Gomez, Dua Lip [see pics]